Sanofi and Regeneron's Dupixent scores a potential sales boost as AbbVie candidate threatens
admin 18th September 2017 Uncategorised 0Sanofi and Regeneron, whose Dupixent is slated to reach peak sales of at least $4 billion, keep pumping out new data that they hope will help get it there sooner rather than later.
More: Sanofi and Regeneron's Dupixent scores a potential sales boost as AbbVie candidate threatens
Source: fierce